CNBC's Final Trades: Biotech, CVS Health, Walt Disney And This Stock That Could Benefit From Taiwan Semiconductor's Earnings Release


On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management chose SPDR S&P Biotech ETF XBI.

Jason Snipe of Odyssey Capital Advisors said he likes CVS Health Corp CVS. “It’s trading at 11 times forward, 12% free cash flow yield, a little over 2% dividend yield and long-term growth rate above 6%. I like it here,” Snipe mentioned.

Check out other health care stocks making moves in the premarket.

Farr, Miller & Washington’s Michael Farr named Walt Disney Co DIS as his final trade. “Streaming business is working, parks are full, Thor Love and Thunder $143 million in the box office, 16% growth rate, 16 times earnings,” Farr said. The stock is trading “at an all-time low,” he added.

Joseph Terranova of Virtus Investment Partners chose Advanced Micro Devices, Inc. AMD ahead of Taiwan Semiconductor Mfg. Co. Ltd’s TSM earnings release.

Photo via Shutterstock. 

Posted In: Long IdeasMediaTrading IdeasBryn TalkingtonCNBCFarrJason SnipeJoseph TerranovaMichael FarrMiller & WashingtonOdyssey Capital AdvisorsRequisite Capital ManagementVirtus Investment Partners